What is Inspire Medical Systems Inc?
, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
INSP · Verdict
Strong reward · low risk
INSP stands out on growth and cash flow, but watch the valuation signal.
Based on 88% data coverage
INSP · Verdict
Revenue +30.8% CAGR
9% free-cash-flow margin
Interest covered 371.9×
16% net margin · 20% ROE
Above average
P/E 49.8× · PEG 1.58
Model-based scoring. For information only — not financial advice.
, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 1.72B, and a P/E ratio of 12.1x.
The scoring profile indicates a strong reward potential, driven primarily by growth and profitability. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.